Brain Neoplasms: all 1,993 studies
Page 15 of 20. Open to participants first (516), then studies with results posted, then the rest; newest registration first within each.
- Vasopressor Effects in Anesthetized PatientsCompletedNCT02713087Phase 4
- Brain Relaxation With Mannitol and FurosemideCompletedNCT02712476Not applicable
- Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent GlioblastomaCompletedNCT02709226Phase 1
- Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in InfantsCompletedNCT02708056Phase 4
- Fluid Therapy During Brain Tumor Resection in ChildrenCompletedNCT02707549Phase 2
- [18F]Dabrafenib Molecular Imaging in Melanoma Brain MetastasisTerminatedNCT02700763Not applicable
- Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation TherapyActive, not recruitingNCT02698254Not applicable
- Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung CancerActive, not recruitingNCT02696993Phase 1/2
- A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade MeningiomasActive, not recruitingNCT02693990Not applicable
- Executive and Socio-cognitive Functions in Survivors of Primary Brain Tumor: Impact on Patients' Quality of LifeStatus unknownNCT02693405Not applicable
- Biomarker Analysis of Central Nervous System TumorsTerminatedNCT02692898
- Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor BiomarkerActive, not recruitingNCT02691923Phase 2
- Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain TumorsTerminatedNCT02684071Phase 2
- Evaluating the Efficacy of a Group Social Skills InterventionCompletedNCT02677142Not applicable
- Understanding and Improving Quality of Life Through a Wireless Activity Tracker: Observational PhaseTerminatedNCT02674945
- Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation TrialStatus unknownNCT02672995Phase 1
- Capecitabine + Bevacizumab in Patients With Recurrent GlioblastomaCompletedNCT02669173Phase 1
- Ipilimumab Combined With a Stereotactic Radiosurgery in Melanoma Patients With Brain MetastasesCompletedNCT02662725Phase 2
- Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)CompletedNCT02658981Phase 1
- Intraoperative Functional UltrasoundCompletedNCT02656407Not applicable
- Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II TrialStatus unknownNCT02655536Phase 2
- Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain MetastasesCompletedNCT02654106Phase 2
- Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsActive, not recruitingNCT02650401Phase 1/2
- Multi-Parametric Brain Cancer MRICompletedNCT02649699Not applicable
- Abemaciclib in Children With DIPG or Recurrent/Refractory Solid TumorsCompletedNCT02644460Phase 1
- Non Invasive Methods for Differential Diagnosis Radionecrosis/Recurrence After Radiosurgery of Brain MetastasesCompletedNCT02636634Phase 3
- Nivo/Ipi Combination Therapy in Symptomatic Brain MetastasesTerminatedNCT02621515Phase 2
- Neurobehavioral Outcomes and Quality of Life in Pediatric Patients With Brain or Head/Neck Tumors Receiving Proton or Photon RadiotherapyStatus unknownNCT02608762
- Medical Treatment Decision Making Using Adaptive Conjoint AnalysisTerminatedNCT02608307
- Temozolomide in Preventing Brain Metastases in Small Cell Lung CancerStatus unknownNCT02605811Phase 2
- Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS MetastasisCompletedNCT02605746Early Phase 1
- Health Related Quality of Life in Pediatric Central Nervous System (CNS) Tumors: A Feasibility Study Utilizing PROMISCompletedNCT02603692
- Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)TherapyCompletedNCT02600065
- Comparing Immobilisation Shells in Cranial RadiotherapyCompletedNCT02599142Not applicable
- Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast CancerTerminatedNCT02598427Phase 1
- Tumor Hypoxia With HX4 PET in Several DiseasesTerminatedNCT02584400Phase 2
- Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced CancerTerminatedNCT02580045
- Tumor Bed Hypofractionated IMRT After Surgery for Patients With Single,Large Brain Metastases From Solid TumorCompletedNCT02576522Not applicable
- Effect of Propofol-Dexmedetomidine on Cerebral Oxygenation and Metabolism During Brain Tumor ResectionCompletedNCT02575521Not applicable
- Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT02575027Not applicable
- Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS TumorsActive, not recruitingNCT02574728Phase 2
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)Active, not recruitingNCT02568267Phase 2
- Stereotactic Radiosurgery (SRS) for Multiple CNS MetsWithdrawnNCT02567643Not applicable
- Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)TerminatedNCT02565433Not applicable
- Esmolol Versus Dexmedetomidine During Intracranial ProceduresStatus unknownNCT02563288Phase 3
- The Use of Fentanyl in General Anesthesia for Craniotomy With or Without 0.5% Levobupivacaine Scalp BlockCompletedNCT02558569Phase 4
- IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain MetastasesTerminatedNCT02556593Phase 2
- Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain MetastasisCompletedNCT02537600Phase 2
- A Comparison of the Effect of 1.5 Versus 3% NaCl on Brain Relaxation and MicrocirculationCompletedNCT02537106Not applicable
- Frailty as a Predictor of Neurosurgical Outcomes in Brain Tumor PatientsCompletedNCT02530749
- EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory GlioblastomaWithdrawnNCT02521090Phase 1/2
- Illness Management and Parental Adjustment to Cancer TreatmentCompletedNCT02505165Not applicable
- Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain TumorsCompletedNCT02502708Phase 1
- Cognitive Intervention After a Brain TumorCompletedNCT02489071Not applicable
- Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial LesionsStatus unknownNCT02478346Phase 4
- A Study of Fotemustine(FTM) Vs FTM and Ipilimumab (IPI) or IPI and Nivolumab in Melanoma Brain MetastasisStatus unknownNCT02460068Phase 3
- Methotrexate Infusion Into Fourth Ventricle in Children With Recurrent Malignant Fourth Ventricular Brain TumorsCompletedNCT02458339Phase 1
- HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain TumorsCompletedNCT02457845Phase 1
- Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral SclerosisCompletedNCT02457715
- Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER)Status unknownNCT02452294Phase 2
- Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNSCompletedNCT02452216Early Phase 1
- Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain TumorsCompletedNCT02444546Phase 1
- T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS TumorsActive, not recruitingNCT02442297Phase 1
- Methionine and PBR28-PET (Peripheral Benzodiazepine Receptors) in Brain Metastases Following RadiosurgeryTerminatedNCT02433171
- Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor PrimaryActive, not recruitingNCT02429570Not applicable
- Assessment of Cognitive Functions and Quality of Life in Patients Undergoing Surgery for Supratentorial Brain TumorStatus unknownNCT02428972Not applicable
- NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung CancerWithdrawnNCT02425072Phase 2
- Safety Study of Afatinib for Brain CancerCompletedNCT02423525Phase 1
- A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and CaregiversCompletedNCT02409121Not applicable
- Spinal Motor Evoked Potentials in Brain SurgeryStatus unknownNCT02402075
- Neurocognitive Outcome of Conformal WBRT w/wo Hippocampal Avoidance for Brain MetastasesStatus unknownNCT02393131Not applicable
- Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective RegistryCompletedNCT02389855
- Use of Fluorescein Dye for the Removal of Brain TumorsCompletedNCT02389530
- Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid TumorsActive, not recruitingNCT02389309Phase 1
- Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain MetastasesStatus unknownNCT02385136Phase 1/2
- Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and CaregiversActive, not recruitingNCT02375841
- Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain MetastasesActive, not recruitingNCT02374242Phase 2
- PET Imaging of Intracranial Cancers With 18F-FSPGTerminatedNCT02370563Phase 1
- Tryptophan Metabolism in Human Brain TumorsCompletedNCT02367469
- Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or MedulloblastomaActive, not recruitingNCT02359565Phase 1
- Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain MetastasesTerminatedNCT02353000Not applicable
- NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First RelapseWithdrawnNCT02348255Phase 2
- Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain TumorsCompletedNCT02338037Early Phase 1
- Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)Status unknownNCT02338011Phase 2/3
- FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain LesionsWithdrawnNCT02328300
- Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance ImagingCompletedNCT02311556Phase 1
- SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial AccessWithdrawnNCT02307604
- D2C7 for Adult Patients With Recurrent Malignant GliomaCompletedNCT02303678Phase 1
- High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain MetastasesStatus unknownNCT02284490Phase 2
- Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain MetastasesTerminatedNCT02279992Early Phase 1
- Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic RadiosurgeryWithdrawnNCT02277561Not applicable
- Assistance in Neurosurgery (ExtempoRMN)Status unknownNCT02272452
- Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain MetastasesCompletedNCT02265549
- Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation TherapyCompletedNCT02259218
- A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood CancerActive, not recruitingNCT02256137
- Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLCStatus unknownNCT02250846Phase 2
- MRI Perfusion on T1 and T2 Brain Lesion(s)CompletedNCT02250755Not applicable
- Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent GliomaWithdrawnNCT02241668Not applicable
- Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant GliomasCompletedNCT02238496Phase 1
- Quality of Recovery Awake Versus Asleep CraniotomyCompletedNCT02228993